HemaSphere (Aug 2020)

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

  • Ruth Wester,
  • Sonja Zweegman,
  • Bronno van der Holt,
  • Marie José Kersten,
  • Edo Vellenga,
  • Marinus van Marwijk-Kooy,
  • Emelie Asselbergs,
  • Okke de Weerdt,
  • Monique C. Minnema,
  • Sarah Lonergan,
  • Antonio Palumbo,
  • Annemiek Broijl,
  • Pieter Sonneveld

DOI
https://doi.org/10.1097/HS9.0000000000000370
Journal volume & issue
Vol. 4, no. 4
p. e370

Abstract

Read online

No abstracts available.